412 related articles for article (PubMed ID: 17262715)
21. Recent origin of human immunodeficiency virus type 1 variants in resting CD4+ T lymphocytes in untreated and suboptimally treated subjects.
Karlsson AC; Lindkvist A; Lindbäck S; Gaines H; Sönnerborg A
J Infect Dis; 2001 Dec; 184(11):1392-401. PubMed ID: 11709781
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.
Derdeyn CA; Kilby JM; Miralles GD; Li LF; Sfakianos G; Saag MS; Hockett RD; Bucy RP
J Infect Dis; 1999 Dec; 180(6):1851-62. PubMed ID: 10558941
[TBL] [Abstract][Full Text] [Related]
23. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
24. [Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA].
Gariglio R; Taborda MA; Bortolozzi R; McDermott JL; Martini I; Borgognone M; Villanova GV; Varnier OE; Giri AA
Medicina (B Aires); 2004; 64(5):419-28. PubMed ID: 15560543
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 dynamics in vivo: implications for therapy.
Simon V; Ho DD
Nat Rev Microbiol; 2003 Dec; 1(3):181-90. PubMed ID: 15035022
[TBL] [Abstract][Full Text] [Related]
26. In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation.
Moriuchi H; Moriuchi M; Mizell SB; Ehler LA; Fauci AS
J Infect Dis; 2000 Jun; 181(6):2041-4. PubMed ID: 10837189
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
[TBL] [Abstract][Full Text] [Related]
28. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
Pippi F
Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
[TBL] [Abstract][Full Text] [Related]
29. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes.
Huang J; Wang F; Argyris E; Chen K; Liang Z; Tian H; Huang W; Squires K; Verlinghieri G; Zhang H
Nat Med; 2007 Oct; 13(10):1241-7. PubMed ID: 17906637
[TBL] [Abstract][Full Text] [Related]
30. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.
Han Y; Lassen K; Monie D; Sedaghat AR; Shimoji S; Liu X; Pierson TC; Margolick JB; Siliciano RF; Siliciano JD
J Virol; 2004 Jun; 78(12):6122-33. PubMed ID: 15163705
[TBL] [Abstract][Full Text] [Related]
31. Can HIV infection be eradicated through use of potent antiviral agents?
Josefsson L; Dahl V; Palmer S
Curr Opin Infect Dis; 2010 Dec; 23(6):628-32. PubMed ID: 20847693
[TBL] [Abstract][Full Text] [Related]
32. Genetic analyses reveal structured HIV-1 populations in serially sampled T lymphocytes of patients receiving HAART.
Potter SJ; Lemey P; Dyer WB; Sullivan JS; Chew CB; Vandamme AM; Dwyer DE; Saksena NK
Virology; 2006 Apr; 348(1):35-46. PubMed ID: 16455126
[TBL] [Abstract][Full Text] [Related]
33. Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity.
Barbour JD; Hecht FM; Little SJ; Markowitz M; Daar ES; Kelleher AD; Routy JP; Campbell TB; Rosenberg ES; Segal MR; Weidler J; Grant RM
AIDS; 2006 Oct; 20(16):2123-5. PubMed ID: 17053362
[TBL] [Abstract][Full Text] [Related]
34. CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy.
Wolbers M; Battegay M; Hirschel B; Furrer H; Cavassini M; Hasse B; Vernazza PL; Bernasconi E; Kaufmann G; Bucher HC;
Antivir Ther; 2007; 12(6):889-97. PubMed ID: 17926643
[TBL] [Abstract][Full Text] [Related]
35. Eliminating HIV-1 reservoirs.
Pomerantz RJ
Curr Opin Investig Drugs; 2002 Aug; 3(8):1133-7. PubMed ID: 12211403
[TBL] [Abstract][Full Text] [Related]
36. Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.
Quivy V; De Walque S; Van Lint C
Subcell Biochem; 2007; 41():371-96. PubMed ID: 17484137
[TBL] [Abstract][Full Text] [Related]
37. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
38. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.
Trono D; Van Lint C; Rouzioux C; Verdin E; Barré-Sinoussi F; Chun TW; Chomont N
Science; 2010 Jul; 329(5988):174-80. PubMed ID: 20616270
[TBL] [Abstract][Full Text] [Related]
39. Immunological responses during a virologically failing antiretroviral regimen are associated with in vivo synonymous mutation rates of HIV type-1 env.
Mens H; Jørgensen LB; Kronborg G; Schønning K; Benfield T
Antivir Ther; 2009; 14(3):413-22. PubMed ID: 19474475
[TBL] [Abstract][Full Text] [Related]
40. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
